Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 322 for “"NERVOUS SYSTEM DISEASES"”.
-
A survey of central nervous system diseases of Michigan cattle
Thesis (M.S.)--Michigan State University. Dept. of Pathology, 1973
-
Nervous system diseases in the first half of the 19th century in Vilnius /
… perception, diagnosis, and treatment methods of nervous system (NS) diseases in the first half of the 19th century in Vilnius. Patients with apoplexy, encephalitis, arachnoiditis, myelitis, hydrophobia, tetanus, sleep disorders, St. Vitus‘ dance, acute and chronic hydrocephalus were examined and …
-
The Utility of Immune Profiling on Cerebrospinal Fluid to Diagnose Central Nervous System Diseases in Dogs
Central nervous system (CNS) diseases in dogs can be challenging to diagnose due to non-specific clinical findings. Cerebrospinal fluid (CSF) is routinely collected as part of the neurological work-up. Our long-term goal is to use immune profiling, i.e. lymphocyte antigen receptor repertoire …
-
Identification and temporal stability of conformational epitopes of autoantibodies against Myelin Oligodendrocyte Glycoprotein recognized by patients with different inflammatory central nervous system diseases
… be localized on the outermost sheath of central nervous system (CNS) myelin. Due to this localization, MOG is accessible to antibodies. Anti-MOG antibodies are demyelinating and enhance clinical symptoms in a number of animal models of CNS inflammation. Autoantibodies recognizing conformationally …
-
CHITOSAN AND ITS DERIVATIVE NANOPARTICLES FOR DRUG DELIVERY INTO BRAIN USING INTRANASAL ADMINISTRATION: PREPARATION, CHARACTERIZATION, IN VITRO AND IN VIVO EVALUATION
… entry of most drugs for the treatment of central nervous system diseases. To overcome this problem and enhance the drug permeability into brain, we propose using carboxymethyl chitosan and chitosan nanoparticles as carriers to deliver drugs intra-nasally to enhance the brain drug concentration and …
-
Analysis of Cell-Cell Interactions in the Formation of Drosophila Antennal Lobes
… of Neuroglian and Limk have been linked to human nervous system diseases, CRASH syndrome and Williams syndrome, respectively. The characterization of these two conserved genes in the Drosophila brain extends our knowledge of their cellular functions and helps to shed light on the pathology of …
-
Η ΔΙΕΡΕΥΝΗΣΗ ΤΗΣ ΟΣΦΡΗΤΙΚΗΣ ΛΕΙΤΟΥΡΓΙΑΣ ΣΤΗ ΝΕΥΡΟΛΟΓΙΑ: ΟΙ ΟΣΦΡΗΤΙΚΕΣ ΔΙΑΤΑΡΑΧΕΣ ΣΤΗ ΝΟΣΟ ΤΟΥ PARKINSON
… METHODS OF EXPLORATION OF THE OLFACTORY SYSTEM. EXISTING DATA ABOUT OLFACTION IN CENTRAL NERVOUS SYSTEM DISEASES. PROPOSITION ABOUT A SIMPLE, CLINICAL, METHOD OF EXPLORATION AND APPLICATION IN A POPULATION OF 80 PATIENTS WITH PARKINSON'S DISEASE. AN OLFACTORY DEFICIT CONCERNING ODOUR …
-
Asymmetric epoxidation of enol ethers and esters using iminium salt catalysts synthesis of α-Hydroxy-Carbonyls
… B 74 which used for the treatment of central nervous system diseases in traditional Chinese medicine.
-
Teaching an old drug new tricks : exploring formulation and route of delivery methods for repurposing drugs to treat CNS diseases
A major barrier to the treatment of central nervous system delivery is the ability to target drug delivery to the brain. The brain is protected by the blood-brain barrier, making it difficult for both small and especially large molecule drugs to reach their sight of action. With recent advancements …
-
Dendrimer-Based Proteosomal Degradation of Indoleamine 2,3-Dioxygenase 1(IDO1)
… It plays a key role in pathology of most central nervous system diseases such as Alzheimer’s, Stroke, Multiple Sclerosis, Autism, Traumatic Brain Injury, Gliomas. Therapeutics for neurological disorders take 35% longer to develop than drugs for other disorders since challenges remain on …
-
Investigating leukocyte infiltration: A tissue-engineered brain microvessel model
… in most brain pathologies. Many central nervous system diseases are affected by a dysregulation of the neuroinflammatory response leading to changes in leukocyte transmigration into the CNS, release of inflammatory mediators, (cytokines, MMPs) and increase in barrier permeability. Gaining …
-
Overcoming blood-brain barrier via nanobiotechnology
Central nervous system diseases, including neurodegenerative diseases and brain malignancies, remain a critical medical challenge. Nanoparticle-enabled therapy and diagnosis have demonstrated promises to address brain diseases. However, one of the physical barriers is the blood-brain barrier (BBB), …
-
DEVELOPMENT OF MINIMALLY-INVASIVE OPTICAL NEUROIMAGING SYSTEMS FOR CLINICAL HELMET IMPLEMENTATION & MONITORING OF FREELY MOVING ANIMALS
There are more than a thousand neural and nervous system diseases according to NIH1. The severity and burden of diseases in general is often reported as disability-adjusted life years (DALYs). The top 50 causes of DALYs include a number of the brain diseases such as epilepsy, stroke, dementia, and …
-
Interactive Real Time Deep Brain Stimulation System
… a high potential to control and treat central nervous system diseases through neuromodulation. DBS utilizes through implanted electrodes that are inserted in the targeted brain structure. Being an emerging technology; neuromodulation introduces many challenges that are not yet comprehensively …
-
Self-assembling silk hydrogels as a mesenchymal stem cell support matrix for stroke
… cell delivery (MSC) platform for central nervous system diseases, especially stroke.
-
Profesinės ligos Lietuvoje 1973-1978 m /
… of Study Describe tendencies of occupational diseases in Lithuania in 1973-1978. Objectives 1. Set the number of occupational diseases and the incidence rate of change in Lithuania in 1973-1978. 2. Determine the distribution of occupational diseases according to risk factors, disease groups, …
-
NOVEL POLY(AMIDOAMINE) NANOPARTICLES DESIGNED FOR DRUG DELIVERY TO THE CENTRAL NERVOUS SYSTEM
With the aging population, central nervous system diseases are becoming increasingly widespread. However, the treatment of such diseases represents a challenge mainly due to the presence of the blood-brain barrier, which effectively blocks most of drugs to pass into the central nervous system and …
-
Investigating the protective effects of intestinal GABA[subscript A] receptor activation on an animal model of Multiple Sclerosis
… produced by neurons in the central nervous system (CNS) and by some species of intestinal bacteria. GABAA receptors are found not only in the CNS, but also in T cells and within the intestines. Past studies have indicated that GABA can have an anti-inflammatory effect and production …
-
Cardiovascular components of organophosphorus-induced delayed neuropathy
The focus of this study was to assess the cardiovascular effects in hens of a single 2.5 mg/kg intramuscular injection of phenyl saligenin phosphate (PSP) into the breast muscle. Parameters were measured at 1, 3, 7, and 20 days post treatment. All hens developed clinical signs of delayed neuropathy …
-
Long-term Effects of Notch1 Signaling on Neural Stem Cells following Traumatic Brain Injury
Traumatic brain injury (TBI) is a devastating problem which stands as a leading cause of death and disability. The elderly is significantly affected by TBI, typically as the result of falls, and recovery is especially limited. This, in part, is associated with decreased tissue-specific stem cell …
Page 1 of 17